l-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a thermal breakdown product of a meperidine-like narcotic used by drug abusers as a heroin substitute, produces Parkinsonian symptoms in humans and primates. The nigrostriatal toxicity is not due to MPTP itself but to one or more oxidation products resulting from the action of monoamine oxidase (MAO) on this tertiary allylamine. Both MAO A and B catalyse the oxidation of MPTP to the 1-methyl-4-phenyl-2,3-dihydropyridinium species (MPDP+), which undergoes further oxidation to the fully aromatic 1-methyl-4-phenylpyridinium species (MPP+). 
INTRODUCTION
In 1983, Langston et al. reported that the Parkinsonian symptoms observed in a group of street drug users was caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, Fig. 1 ). Subsequent studies have documented that MPTP is an effective neurotoxin that selectively destroys nigrostriatal cells in susceptible species (Bums et al., 1983; Langston et al., 1983; Kolata, 1983) . The close similarities between MPTP-induced Parkinsonism and idiopathic Parkinson's disease have led to a concerted effort to elucidate the molecular events involved in the mechanism of neurotoxicity of MPTP (Markey et al., 1986) .
Although MPTP is lipophilic and crosses the blood/ brain barrier, its inherent chemical stability suggested to us that its neurotoxic properties might be mediated by chemically reactive metabolites generated within the central nervous system. The observation that rat brain mitochondrial preparations catalysed the oxidation of MPTP to the 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) species (Fig. 1 ) in vitro provided support for this proposal (Chiba et al., 1984; Castagnoli et al., 1985) . Since this catalytic activity ofbrain mitochondrial preparations was inhibited by deprenyl but not clorgyline, we proposed that the oxidation of MPTP was catalysed by MAO B (Chiba et al., 1984) . These findings prompted studies in vivo, which have shown that pretreatment with inhibitors of MAO B completely protects susceptible animals against the neurotoxic effects of MPTP (Heikkila et al., 1984; Langston et al., 1984 (Chiba et al., 1985a; Peterson et al., 1985) . The present paper is a detailed account of studies that have been reported briefly in two preliminary communications (Salach et al., 1984; Singer et al., 1985) .
EXPERIMENTAL Materials MAO B from ox liver mitochondria was isolated by the procedure of Salach (1979) , and traces of haem protein Vol. 235 Abbreviations used: MAO, monoamine oxidase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPDP+, 1-methyl-4-phenyl-2,3-dihydropyridinium species; MPP+, 1-methyl-4-phenylpyridinium species.
were removed by centrifugation in a sucrose gradient (Weyler & Salach, 1981) . MAO A was purified to > 90"% homogeneity from human placental mitochondria (Weyler & Salach, 1985 (Salach et al., 1984; Singer et al., 1985) .
Methods
The activities of MAO A and B were determined spectrophotometrically at 30°C by using strict initial-rate measurements (30-120 s reaction periods), the former with kynuramine and the latter with benzylamine as substrate (Salach, 1979; Weyler & Salach, 1985 (Penefsky, 1977 (Chiba et al., 1984) , the observed oxidation rates were impressive given that tertiary amines are considered to be only very slowly oxidized in the presence of MAO (Blaschko, 1963) . MAO B catalysed the oxidation of MPTP at a rate of 1.71 nmol/min per,g of enzyme, 4000 of that observed with benzylamine, the most rapidly oxidized substrate for the enzyme in steady-state assays. The Km value for this reaction (0.30 mM) was even lower than that for benzylamine (0.38 mM). The rate of oxidation by MAO A also was substantial (0.1 1 nmol/min per mg of enzyme), and the Km value, 0.14 mm, is similar to that for kynuramine, a preferred substrate (Salach et al., 1984) .
Our initial studies on the rates of the MAO-catalysed oxidation ofMPTP suggested a stoichiometric conversion into MPDP+. This product is a relatively unstable molecule which, at millimolar concentrations, undergoes spontaneous disproportionation to MPTP and MPP+ (Peterson et al., 1985) . (Salach et al., 1984 competitive phase of inhibition before irreversible inactivation of the enzyme (Singer, 1985 Fig. 2 shows this time-dependent irreversible inactivation of MAO A and MAO B by MPTP. The first-order rate constants for inactivation by MPTP (5 mM) were 1.0 x 10-2 and 3.4 x 10-2 min-' for MAO A and MAO B respectively. The linearity of the exponential plots together with the protection against inactivation Vol. 235 observed when normal substrates were added before the addition of MPTP, was indicative of a mechanism-based or 'suicide' inactivation of MAO (Singer, 1985) . Similar conclusions have been reached by Fuller & HemrickLuecke (1985) Further characterization of the inactivation process was afforded by timed spectral analyses of the reaction between MPTP and MAO B (Fig. 3) . The spectrum of the fully active, oxidized enzyme (Amax 460 nm) is shown in the inset. The first changes evident (30 s) were a loss of the 460 nm chromophore due to reduction of the 8a-S-cysteinyl FAD moiety and the appearance of a band at 343 nm representing the formation of the 2-electron oxidation product, MPDP+. The intensity of the 343 nm band increased with time, but after 15 min began to decline, presumably as a result of the further oxidation of MPDP+ to MPP+. The spectral analyses revealed a shoulder at 410 nm after 15 min, which progressively increased in intensity. Since this absorption band may extend beyond 460 nm, it was not possible to determine if the flavin moiety undergoes reoxidation at a later time. Fig. 4 shows a comparison of the changes in A410 with loss of enzyme activity as a function of time. Although suggestive of a relationship between the two events, the data do not necessarily indicate that enzyme inactivation is caused by (or reflected in) the formation of the compound absorbing at 410 nm. The molecular nature of this species remains to be determined. However, it binds to the enzyme tightly enough to remain with the protein during gel-exclusion chromatography and precipitation with trichloroacetic acid.
Indirect evidence that a covalently bound flavin group is not involved in the inactivation of MAO B and MPTP is that, upon purification, the flavin peptides obtained by The enzyme (3.8 ml, 2.3 mg/ml) in 50 mM-Hepes buffer, pH 7.2, containing 2 mg of Triton X-100/ml, was incubated with 4.9 mM-MPTP at 30°C. At the times shown, 0.5 ml aliquots were rapidly chilled and centrifuged through 5 ml columns of Sephadex G-25 equilibrated with the same buffer. An equal volume (0.5 ml) of the same buffer was used to elute the protein from the columns. Spectra were taken immediately. Loss of activity and protein concentration were measured as described above. The protein concentrations did not vary by more than 5 %. (Ghisla et al., 1973) . The only other nucleophilic group known to be present at the active site of MAO is the -SH group. Thiol groups of proteins characteristically form adducts with carbonyls (thiohemiacetals or thiohemiketals), which are usually stabilized by the tertiary structure of the native protein, but which undergo gradual dissociation once the protein is denatured. For example, mechanism-based inactivation of MAO B by trans-phenylcyclopropylamine (Paech et al., 1980) involves the formation of a thiohemiacetal adduct between the active-site thiol and cinnamaldehyde (Silverman, 1983) . Such adducts tend to dissociate slowly, even with prolonged dialysis of the native enzyme against preferred MAO substrates (Hellerman & Erwin, 1968) . In this context it is noteworthy that the activity of MPTP-inactivated MAO B could be partially restored by dialysis over a period of 70 h, during which time control samples of the enzyme retained full activity (Fig. 5) .
Despite over half a century of research on MAO, a re-examination of the substrate specificities of both forms of the enzyme appears necessary, particularly with regard disease (Calne & Langston, 1983; Langston et al., 1983; Lewin, 1985; . It is clear that MAO A and B not only catalyse the oxidation of biogenic amines such as dopamine (3,4-dihydroxyphenethylamine), noradrenaline and serotonin, but also play an important role in the processing of xenobiotics. This may result in detoxification or, as is the case of MPTP, the conversion of a biologically unreactive molecule into highly toxic metabolites. The chemical reactivity of intermediates formed during the MAO-catalysed oxidations of MPTP presumably is responsible for the mechanism-based inactivation of the enzymes. Whether such oxidation products share a common molecular identity with those responsible for the selective cytotoxic effects on central dopaminergic neurons remains to be elucidated.
